RNA FY 2019 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+511.9% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$17M-747.4% margin

Net Income

-$25M-1066.6% margin

EPS (Diluted)

$-0.86

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$406,000

Balance Sheet

Total Assets

$97M

Total Liabilities

$162M

Stockholders' Equity

-$65M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$379,000	+511.9%
Gross Profit	$2M	-$8M	+128.8%
Operating Income	-$17M	-$10M	-65.1%
Net Income	-$25M	-$12M	-107.3%